Adjusting insulin delivery rates

US12303668B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12303668-B2
Application numberUS-202117451128-A
CountryUS
Kind codeB2
Filing dateOct 15, 2021
Priority dateJan 14, 2016
Publication dateMay 20, 2025
Grant dateMay 20, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future blood glucose values for each profile and target blood glucose levels, delivering insulin for a second time interval that corresponds to a first action of the first profile, generating a second plurality of insulin delivery profiles for a third time interval, projecting a second plurality of future blood glucose values for each profile of the second plurality of profiles for the third time interval, and delivering a second dose of insulin for a fourth time interval shorter than the third time interval.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of providing insulin delivery instructions for an insulin delivery device, the method comprising: selecting a first user-specific basal delivery profile permutation from a plurality of user-specific basal delivery profile permutations, the first user-specific basal delivery profile permutation having an intended basal rate and an intended delivery time duration for the intended basal rate; generating insulin delivery instructions comprising the intended basal rate of the first user-specific basal delivery profile permutation and a first variable delivery time duration relative to the intended delivery time duration of the first user-specific basal delivery profile permutation; and providing the generated insulin delivery instructions to the insulin delivery device. 2. The method of claim 1 , further comprising: receiving blood glucose level data related to a user during the first variable delivery time duration; estimating a future blood glucose level of the user based at least partially on the received blood glucose level data; based at least partially on the estimated future blood glucose level, selecting a second user-specific basal delivery profile permutation from the plurality of user-specific basal delivery profile permutations, the second user-specific basal delivery profile permutation having an intended basal rate and an intended delivery time duration for the intended basal rate; generating updated insulin delivery instructions comprising the intended basal rate of the second user-specific basal delivery profile permutation and a second variable time duration relative to the intended delivery time duration of the second user-specific basal delivery profile permutation; and providing the generated updated insulin delivery instructions to the insulin delivery device. 3. The method of claim 1 , further comprising: receiving blood glucose level data related to a user during the first variable delivery time duration; estimating a future blood glucose level of the user based at least partially on the received blood glucose level data; based at least partially on the estimated future blood glucose level, generating updated insulin delivery instructions to continue to deliver medication according to the intended basal rate of the first user-specific basal delivery profile permutation for a second variable time duration relative to the intended delivery time duration of the first user-specific basal delivery profile permutation; and providing the generated updated insulin delivery instructions to the insulin delivery device. 4. The method of claim 3 , wherein the first variable delivery time duration and the second variable time duration together are substantially equal to the intended delivery time duration of the first user-specific basal delivery profile permutation. 5. The method of claim 1 , wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation. 6. The method of claim 1 , wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation by one or more hours or by less than sixty minutes. 7. The method of claim 1 , further comprising: responsive to a lack of up-to-date blood glucose data and a passage of the first variable delivery time duration, generating adjusted insulin delivery instructions comprising an adjusted basal rate; and providing the adjusted insulin delivery instructions to the insulin delivery device. 8. The method of claim 7 , wherein the adjusted insulin delivery instructions comprise a generic basal rate. 9. The method of claim 1 , further comprising: receiving one or more user-specific dosage parameters; and generating the plurality of user specific basal delivery profile permutations based at least partially on the received one or more user-specific dosage parameters. 10. The method of claim 9 , wherein receiving one or more user-specific dosage parameters comprises receiving the one or more user-specific dosage parameters at a device remote to the insulin delivery device. 11. The method of claim 9 , wherein receiving one or more user-specific dosage parameters comprises receiving the one or more user-specific dosage parameters via wireless communication. 12. The method of claim 1 , wherein each of the plurality of user-specific basal delivery profile permutations comprises a projected effect of a respective basal delivery profile on a blood glucose level of a user. 13. A system comprising: a blood glucose monitor; an insulin delivery device; a controller remote from the blood glucose monitor and the insulin delivery device, the controller configured to: select a first user-specific basal delivery profile permutation from a plurality of user-specific basal delivery profile permutations, the first user-specific basal delivery profile permutation having an intended basal rate and an intended delivery time duration for the intended basal rate; generate insulin delivery instructions comprising the intended basal rate of the first user-specific basal delivery profile permutation and a first variable delivery time duration relative to the intended delivery time duration of the first user-specific basal delivery profile permutation; transmit the generated insulin delivery instructions to the insulin delivery device receive blood glucose level data related to a user during the first variable delivery time duration from the blood glucose monitor; estimate a future blood glucose level of the user based at least partially on the received blood glucose level data; based at least partially on the estimated future blood glucose level, determine whether a change to the intended basal rate or a time duration for which the intended basal rate is currently instructed to be delivered is warranted; responsive to a determination that a change to the intended basal rate or the time duration for which the intended basal rate is currently instructed to be delivered is warranted, select a new user-specific basal delivery profile permutation from the plurality of user-specific basal delivery profile permutations, the new user-specific basal delivery profile permutation having a new intended basal rate and a new intended delivery time duration for the new intended basal rate; and generate new insulin delivery instructions comprising the new intended basal rate of the new user-specific basal delivery profile permutation and a second variable delivery time duration relative to the new intended delivery time duration of the new user-specific basal delivery profile permutation. 14. The system of claim 13 , wherein the controller is further configured to repeatedly receive blood glucose level data related to the user, estimate future blood glucose levels of the user, determine whether changes are warranted, and select additional new user-specific basal delivery profile permutations. 15. The system of claim 13 , wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal delivery profile permutation. 16. The system of claim 15 , wherein the second variable delivery time duration is less than the new intended delivery time duration of the first user-specific basal delivery profile permutation. 17. The system of claim 13 , wherein the first variable delivery time duration is less than the intended delivery time duration of the first user-specific basal del

Assignees

Inventors

Classifications

  • with memories providing a history of measured variating parameters of apparatus or patient · CPC title

  • using modem, internet or Bluetooth® · CPC title

  • sublocal, e.g. between console and disposable · CPC title

  • of the skin patch type · CPC title

  • Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12303668B2 cover?
A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future bl…
Who is the assignee on this patent?
Insulet Corp
What technology area does this patent fall under?
Primary CPC classification A61M5/142. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).